WO2003101443A1 - The use of milnacipran for the treatment of tension-type headache - Google Patents
The use of milnacipran for the treatment of tension-type headache Download PDFInfo
- Publication number
- WO2003101443A1 WO2003101443A1 PCT/DK2003/000351 DK0300351W WO03101443A1 WO 2003101443 A1 WO2003101443 A1 WO 2003101443A1 DK 0300351 W DK0300351 W DK 0300351W WO 03101443 A1 WO03101443 A1 WO 03101443A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tension
- milnacipran
- type headache
- treatment
- headache
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004508801A JP2005527634A (en) | 2002-05-30 | 2003-05-27 | How to use milnacipran for the treatment of tension headache |
CA002485355A CA2485355A1 (en) | 2002-05-30 | 2003-05-27 | The use of milnacipran for the treatment of tension-type headache |
EP03724898A EP1513510A1 (en) | 2002-05-30 | 2003-05-27 | The use of milnacipran for the treatment of tension-type headache |
AU2003227519A AU2003227519A1 (en) | 2002-05-30 | 2003-05-27 | The use of milnacipran for the treatment of tension-type headache |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200200835 | 2002-05-30 | ||
DKPA200200835 | 2002-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003101443A1 true WO2003101443A1 (en) | 2003-12-11 |
Family
ID=29594981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2003/000351 WO2003101443A1 (en) | 2002-05-30 | 2003-05-27 | The use of milnacipran for the treatment of tension-type headache |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040019115A1 (en) |
EP (1) | EP1513510A1 (en) |
JP (1) | JP2005527634A (en) |
AU (1) | AU2003227519A1 (en) |
CA (1) | CA2485355A1 (en) |
WO (1) | WO2003101443A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704527B2 (en) * | 2002-10-25 | 2010-04-27 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
US10399322B2 (en) * | 2014-06-11 | 2019-09-03 | Applied Nanostructured Solutions, Llc | Three-dimensional printing using carbon nanostructures |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000015223A1 (en) * | 1998-09-15 | 2000-03-23 | Eli Lilly And Company | Treatment of persistent pain |
EP1002794A1 (en) * | 1998-11-18 | 2000-05-24 | FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. | 4-[(Aryl)(aryloxy)methyl]piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5527351A (en) * | 1994-09-21 | 1996-06-18 | Friedman; Mark H. | Treatment of vascular and tension headache atypical facial pain allergic rhinitis and cervical muscle hyperactivity |
EP1499309A4 (en) * | 2002-04-24 | 2008-05-28 | Cypress Bioscience Inc | Prevention and treatment of functional somatic disorders, including stress-related disorders |
-
2003
- 2003-05-27 WO PCT/DK2003/000351 patent/WO2003101443A1/en not_active Application Discontinuation
- 2003-05-27 AU AU2003227519A patent/AU2003227519A1/en not_active Abandoned
- 2003-05-27 JP JP2004508801A patent/JP2005527634A/en not_active Withdrawn
- 2003-05-27 EP EP03724898A patent/EP1513510A1/en not_active Withdrawn
- 2003-05-27 CA CA002485355A patent/CA2485355A1/en not_active Abandoned
- 2003-05-29 US US10/446,783 patent/US20040019115A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000015223A1 (en) * | 1998-09-15 | 2000-03-23 | Eli Lilly And Company | Treatment of persistent pain |
EP1002794A1 (en) * | 1998-11-18 | 2000-05-24 | FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. | 4-[(Aryl)(aryloxy)methyl]piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors |
Also Published As
Publication number | Publication date |
---|---|
US20040019115A1 (en) | 2004-01-29 |
JP2005527634A (en) | 2005-09-15 |
EP1513510A1 (en) | 2005-03-16 |
AU2003227519A1 (en) | 2003-12-19 |
CA2485355A1 (en) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5543434A (en) | Nasal administration of ketamine to manage pain | |
US6372790B1 (en) | Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia | |
AU2008201775B2 (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
HU225534B1 (en) | Pharmaceutical compositions comprising mirtazapine and one or more selective serotonin reuptake inhibitors | |
JP5796959B2 (en) | Tapentadol for the treatment of pain in arthritis | |
JP2001527554A (en) | Composition and method for treating neuropathic pain combining antidepressant and NMDA receptor antagonist | |
RU2592983C2 (en) | Combined therapy including vemurafenib and interferon, for use in treating cancer | |
KR20140025461A (en) | Method for treatment of advanced solid tumors | |
US20040034101A1 (en) | Treatment and prevention of depression secondary to pain (DSP) | |
JP2006083190A (en) | Use of granisetron for treating nausea and vomitting after surgery | |
Matamala et al. | Avoid postoperative pain to prevent its chronification: a narrative review | |
JPH10505087A (en) | Pain relieving composition containing non-narcotic analgesic and painless enhancer | |
JPH09504798A (en) | Use of alfuzosin or terazosin in the treatment of premature ejaculation | |
US20040019115A1 (en) | Use of milnacipran for the treatment of tension-type headache | |
WO2007062837A2 (en) | Use of a 5-ht4 agonist for the treatment of irritable bowel syndrome characterized by mixed or alternating bowel habits | |
US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
US5292497A (en) | Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate | |
JP2011529490A (en) | Methods for treating pain using alpha-2 adrenergic receptor agonists and endothelin receptor antagonists | |
CN110325214A (en) | Low-dose drugs for preventing and treating neure damage combine | |
TW200940049A (en) | Associations for obtaining medicaments for the treatment of bipolar disorders | |
WO2020240279A1 (en) | Intranasal administration of ketamine to cluster headache patients | |
ES2210025T3 (en) | PHARMACEUTICAL AGENT FOR THE TREATMENT OF CONVULSIVE STATES. | |
US6194460B1 (en) | Composition for treating cough induced by angiotensin converting enzyme inhibitors | |
US20020132858A1 (en) | Method for treating sexual disorders | |
WO2004052399A1 (en) | Composition for topical anesthesia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003724898 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2485355 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004508801 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003724898 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003724898 Country of ref document: EP |